SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Genetown
A Gutsy Move: Valeant Runs Super Bowl Commercial For Xifaxan
February 8, 2016
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Emails Reveal Turing, Valeant Price Increases Were Basis for Revenue Growth
February 3, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Valeant Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo
February 2, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Pharm Country
Pershing Square’s Bill Ackman Writes Letter of Apology to Investors, Regrets Investing so Heavily into Valeant
January 28, 2016
 · 
4 min read
Biotech Beach
Valeant’s Novel Business Approach Made It Wall Street’s Darling—Then A Pariah
January 13, 2016
 · 
1 min read
Genetown
Is Pfizer Any Different From Valeant?
January 11, 2016
 · 
1 min read
Business
Valeant Taps Interim CEO While Michael Pearson Remains Hospitalized
January 6, 2016
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Takes Tough Punches as Ackman Cuts Stake to 8.5%
January 4, 2016
 · 
3 min read
Business
Valeant CEO Takes Medical Leave; Executive Team to Run Pharma Firm
December 28, 2015
 · 
4 min read
Load More
IN THE PRESS
AstraZeneca PLC Terminates Valeant’s Brodalumab Development Agreement for Europe
July 1, 2016
 · 
4 min read
Job Trends
Debt-Ridden Valeant to Invest $27.5 Million in Its Canadian Manufacturing Facilities
June 17, 2016
 · 
3 min read
Business
Valeant Appoints Thomas W. Ross, Sr. Lead Independent Director
June 16, 2016
 · 
4 min read
Valeant Announces Launch Of New Preservision AREDS 2 Formula + Multivitamin
June 16, 2016
 · 
3 min read
Deals
Valeant Brings Morgan Stanley on Board to Sell Dermatology Assets
June 14, 2016
 · 
1 min read
Valeant To Participate In FDA Advisory Committee Meeting On July 19
June 10, 2016
 · 
3 min read
Deals
Valeant Mulls Over Selling Egyptian Drugmaker Amoun and Latin American Assets
June 10, 2016
 · 
1 min read
Valeant To Webcast 2016 Annual Meeting Of Shareholders
June 8, 2016
 · 
1 min read
Business
Valeant Reports First Quarter 2016 Financial Results
June 7, 2016
 · 
16 min read
Valeant Receives Additional Notice Of Default Under Indentures Due To Delayed Form 10-Q Filing
June 3, 2016
 · 
2 min read
Load More